Literature DB >> 15699506

Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes.

Enrico di Cesare1, Marcello Previti, Fortunato Lombardo, Nicola Mazzù, Antonino di Benedetto, Domenico Cucinotta.   

Abstract

Recently, the high prevalence of autoantibodies against antigens expressed in exocrine pancreatic cells such as carbonic anhydrase II (ACA) and lactoferrin (ALF) was found in sera from adult Japanese patients with type 1 diabetes. Hence, we determined by ELISA the presence of ACA and ALF both in children (n = 27) and adult (n = 15) Caucasian patients with type 1 diabetes at diagnosis. Among children, ACA were found in one patient (3.7%) and ALF in three (11.1%). Among adults, CAA and ALF were detected in three patients (20%) and in one patient (6.7%), respectively. The prevalence of ACA and ALF observed in our Caucasian patients with type 1 diabetes at diagnosis did not reach the high value previously reported in adult Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15699506     DOI: 10.1196/annals.1337.021

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Abnormalities of the Exocrine Pancreas in Type 1 Diabetes.

Authors:  Martha Campbell-Thompson; Teresa Rodriguez-Calvo; Manuela Battaglia
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 2.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

3.  The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients.

Authors:  Adem Türk; Süleyman Mollamehmetoğlu; Ahmet Alver; Ahmet Menteşe; İrfan Nuhoğlu; Cihangir Erem; Halil İbrahim İmamoğlu
Journal:  Turk J Ophthalmol       Date:  2017-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.